With 2015 looming, many pharmaceutical companies are well down the path of serialization. Most of these companies are designing and ...

Clarkston Consulting recently participated in the GPhA Annual Meeting in Orlando, FL. This signature event creates a forum for generic ...

Recent hype about John Mackey’s “Conscious Capitalism” has drawn attention to the business shift from shareholder to stakeholder value. Increasingly, ...

Most Pharma companies have been taking a “wait and see” approach to starting a Serialization and Traceability initiative, hoping that ...

The 2012 FDA reform bill, which includes a fifth, five-year reauthorization of the Prescription Drug User Fee Act (PDUFA V), ...

Clarkston Consulting is participating – and presenting – this week at the 2012 SAPPHIRE NOW + ASUG Annual Conference in ...

With regulatory requirements looming and a growing desire to prevent counterfeiting, tampering, theft, and diversion, companies must begin to look ...

This week, Joe D’Ambrosio from Clarkston Consulting moderated a panel of industry experts at the most recent CED Biotech Forum.

The Life Sciences industry faces a multitude of challenges and threats moving into 2012, but within each challenge lies great ...

In April 2011, the Food and Drug Administration (FDA) released an update of its strategic priorities, outlining the goals and ...

Over the past decade, in our experience working with Life Sciences companies, we have seen many companies fail to achieve ...